Ether

Ether

SCHEMBL367435

CCOCC.[Cl-].[H+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Ether. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL4300165 0.95
Ether SCHEMBL351216 0.95
Ether SCHEMBL11292739 0.90
Ether SCHEMBL797466 0.90
Ether SCHEMBL18173787 0.90 ALDH1A1 (0.41)
Ether SCHEMBL11648502 0.90 ALDH1A1 (0.41)
Ether SCHEMBL10501726 0.90 ALDH1A1 (0.41)
Ether SCHEMBL10629462 0.90
Ether SCHEMBL626639 0.90 ALDH1A1 (0.41)
Ether SCHEMBL355376 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 314 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117209387-B Salifying and purifying process of esmolol hydrochloride 中国海洋大学 2024-04-26 CN claimed
CN-117263870-A Preparation method of Resmetirom key intermediate III 江西同和药业股份有限公司 2023-12-22 CN claimed
CN-117247525-A Method for preparing polyester based on ring-opening polymerization of organic difunctional catalytic cyclic monomer 南京工业大学 2023-12-19 CN claimed
CN-117209429-A Photoreactive lysine and hydrochloride thereof, preparation method and application 河北百灵威超精细材料有限公司 2023-12-12 CN claimed
WO-2023202464-A1 PURIFICATION METHOD FOR ELECTRON MEDIATOR 英科隆生物技术(杭州)有限公司 2023-10-26 WO claimed
CN-116731071-A Pyrazole bridged phosphine ligand, dinuclear complex and application thereof 上海科技大学 2023-09-12 CN claimed
CN-116253754-A Method for synthesizing high-abundance boron 10 isotope biboronate 中国科学院兰州化学物理研究所 2023-06-13 CN claimed
CN-111362935-B Synthesis method of N-hydroxy tropisetron 梯尔希(南京)药物研发有限公司 2022-08-19 CN claimed
CN-114751857-A Preparation method of indacaterol impurity 梯尔希(南京)药物研发有限公司 2022-07-15 CN claimed
CN-111499575-B Method for preparing lorcaserin 河北师范大学 2022-03-25 CN claimed
CN-113336713-A Preparation method of alkoxy pyrazine derivative and alkoxy pyrazine derivative 中国人民解放军军事科学院军事医学研究院 2021-09-03 CN claimed
CN-111499575-A Method for preparing lorcaserin 河北师范大学 2020-08-07 CN claimed
CN-111362935-A Synthesis method of N-hydroxy tropisetron 梯尔希(南京)药物研发有限公司 2020-07-03 CN claimed
CN-110734405-A Synthesis method of N- (6-aminohexyl) -N '-methyl-2, 2' -biimidazole 华东数字医学工程研究院 2020-01-31 CN claimed
CN-105175339-B A kind of method for preparing dexmedetomidine hydrochloride 辰欣药业股份有限公司 2018-01-16 CN claimed
CN-103992323-B A kind of preparation method of ticagrelor 南通常佑药业科技有限公司 2017-03-29 CN claimed
CN-105541649-A Preparation method of glutamic acid-5-benzyl ester-1-tert-butyl ester hydrochloride GL BIOCHEM (SHANGHAI) LTD 2016-05-04 CN claimed
CN-101602734-B Method for preparing Erlotinib hydrochloride crystal form A ZHEJIANG JIUZHOU PHARM CO LTD 2011-07-20 CN claimed
CN-101602734-A A kind of preparation method of Erlotinib hydrochloride crystal form A ZHEJIANG JIUZHOU PHARMACEUTICA (CN) 2009-12-16 CN claimed
CN-119546656-A Crosslinked fluorocopolymer and a fluorocopolymer composition AGC株式会社 2025-02-28 CN disclosed
CN-119451932-A Fluorine-containing compound, fluorine-containing copolymer and fluorine-containing copolymer composition AGC株式会社 2025-02-14 CN disclosed
CN-118206569-A Azoline ammonium quinoline carboxamide analogue, pharmaceutical composition, preparation method and medical application thereof 上海市针灸经络研究所 2024-06-18 CN disclosed
CN-117209387-B Salifying and purifying process of esmolol hydrochloride 中国海洋大学 2024-04-26 CN disclosed
CN-116655674-B Method for synthesizing high-abundance boron 10 isotope biboronate 中国科学院兰州化学物理研究所 2024-04-16 CN disclosed
CN-110016055-B Organic electroluminescent device and polycyclic compound for organic electroluminescent device 三星显示有限公司 2024-02-23 CN disclosed
WO-2024009764-A1 CROSSLINKED PRODUCT OF FLUORINE-CONTAINING COPOLYMER AND FLUORINE-CONTAINING COPOLYMER COMPOSITION AGC株式会社 2024-01-11 WO disclosed
WO-2024009763-A1 FLUORINE-CONTAINING COMPOUND, FLUORINE-CONTAINING COPOLYMER AND FLUORINE-CONTAINING COPOLYMER COMPOSITION AGC株式会社 2024-01-11 WO disclosed
CN-117263870-A Preparation method of Resmetirom key intermediate III 江西同和药业股份有限公司 2023-12-22 CN disclosed
CN-117247525-A Method for preparing polyester based on ring-opening polymerization of organic difunctional catalytic cyclic monomer 南京工业大学 2023-12-19 CN disclosed
CN-117209429-A Photoreactive lysine and hydrochloride thereof, preparation method and application 河北百灵威超精细材料有限公司 2023-12-12 CN disclosed
CN-117209387-A Salifying and purifying process of esmolol hydrochloride 中国海洋大学 2023-12-12 CN disclosed
CN-116947783-A Purification method of electronic mediator 英科隆生物技术(杭州)有限公司 2023-10-27 CN disclosed
WO-2023202464-A1 PURIFICATION METHOD FOR ELECTRON MEDIATOR 英科隆生物技术(杭州)有限公司 2023-10-26 WO disclosed
CN-116731071-A Pyrazole bridged phosphine ligand, dinuclear complex and application thereof 上海科技大学 2023-09-12 CN disclosed
CN-116655674-A Method for synthesizing high-abundance boron 10 isotope biboronate 中国科学院兰州化学物理研究所 2023-08-29 CN disclosed
CN-113583992-B Reductive amination enzyme and application thereof in secondary amine synthesis 华东理工大学 2023-06-27 CN disclosed
CN-116253754-A Method for synthesizing high-abundance boron 10 isotope biboronate 中国科学院兰州化学物理研究所 2023-06-13 CN disclosed
CN-116003264-A Preparation method of amine compound 长春工业大学 2023-04-25 CN disclosed
CN-113336713-B Preparation method of alkoxy pyrazine derivative and alkoxy pyrazine derivative 中国人民解放军军事科学院军事医学研究院 2023-03-17 CN disclosed
CN-110662541-B Polycyclic amines as opioid receptor modulators 王晓冬 2023-02-10 CN disclosed
EP-3604306-B1 MACROCYCLIC DERIVATIVE OF PYRAZOL[3,4-D]PYRIMIDIN-3-ONE, PHARMACEUTICAL COMPOSITION AND USE THEREOF SHANGHAI DE NOVO PHARMATECH CO LTD (CN) 2022-10-26 EP disclosed
CN-112608286-B Preparation method of high-purity pramipexole 广东红珊瑚药业有限公司 2022-09-30 CN disclosed
CN-112812048-B Preparation method of sodium ion channel retarder CNV1014802 hydrochloride form 北京蓝博特科技有限公司 2022-08-26 CN disclosed
CN-111362935-B Synthesis method of N-hydroxy tropisetron 梯尔希(南京)药物研发有限公司 2022-08-19 CN disclosed
CN-114751857-A Preparation method of indacaterol impurity 梯尔希(南京)药物研发有限公司 2022-07-15 CN disclosed
CN-107311846-B Gem difluoroethyl substituted stilbene and diphenylethane derivatives, and preparation method and application thereof 上海华理生物医药股份有限公司 2022-05-13 CN disclosed
CN-111499575-B Method for preparing lorcaserin 河北师范大学 2022-03-25 CN disclosed
CN-111499575-B Method for preparing lorcaserin 河北师范大学 2022-03-25 CN disclosed
EP-3453707-B1 BENZAZEPINE DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF SHANGHAI DE NOVO PHARMATECH CO LTD (CN) 2022-02-16 EP disclosed
US-11251380-B2 Organic electroluminescence device and polycyclic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2022-02-15 US disclosed
US-11248006-B2 Macrocyclic derivative of pyrazol[3,4-d]pyrimidin-3-one, pharmaceutical composition and use thereof Shanghai De Novo Pharmatech Co., Ltd. (CN) 2022-02-15 US disclosed
CN-113583992-A Reductive amination enzyme and application thereof in secondary amine synthesis 华东理工大学 2021-11-02 CN disclosed
CN-113336713-A Preparation method of alkoxy pyrazine derivative and alkoxy pyrazine derivative 中国人民解放军军事科学院军事医学研究院 2021-09-03 CN disclosed
CN-112851930-A Sulfur-containing polyethylene glycol resin for polypeptide synthesis 苏州金顶生物有限公司 2021-05-28 CN disclosed
CN-112812048-A Preparation method of sodium ion channel blocker CNV1014802 hydrochloride form 北京蓝博特科技有限公司 2021-05-18 CN disclosed
CN-112608286-A Preparation method of high-purity pramipexole 广东红珊瑚药业有限公司 2021-04-06 CN disclosed
CN-111732650-B Continuous flow solid phase reaction preparation of Somaloutide 苏州金顶生物有限公司 2020-12-08 CN disclosed
US-20200377520-A1 MACROCYCLIC DERIVATIVE OF PYRAZOL[3,4-D]PYRIMIDIN-3-ONE, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai De Novo Pharmatech Co., Ltd. (CN) 2020-12-03 US disclosed
WO-2020233669-A1 INDOLE DERIVATIVE-CONTAINING INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 上海翰森生物医药科技有限公司 (CN) 2020-11-26 WO disclosed
CN-111732650-A Continuous flow solid phase reaction preparation of Somaloutide 苏州金顶生物有限公司 2020-10-02 CN disclosed
CN-111732734-A Sulfur-containing polyethylene glycol modified resin 苏州金顶生物有限公司 2020-10-02 CN disclosed
CN-111499575-A Method for preparing lorcaserin 河北师范大学 2020-08-07 CN disclosed
CN-111499575-A Method for preparing lorcaserin 河北师范大学 2020-08-07 CN disclosed
CN-111362935-A Synthesis method of N-hydroxy tropisetron 梯尔希(南京)药物研发有限公司 2020-07-03 CN disclosed
US-10669252-B2 Benzazepine derivative, preparation method, pharmaceutical composition and use thereof Shanghai De Novo Pharmatech Co., Ltd. (CN) 2020-06-02 US disclosed
CN-108395437-B Deuterated compound and medical application thereof 经路纬带信息咨询(北京)有限公司 2020-04-14 CN disclosed
CN-106749048-B Erlotinib hydrochloride crystal form compound and preparation method thereof 山东裕欣药业有限公司 2020-03-20 CN disclosed
EP-3214088-B1 METHOD FOR PRODUCING EUSHEARILIDES UNIV TOKYO SCIENCE FOUND (JP) 2020-02-26 EP disclosed
EP-3604306-A1 MACROCYCLIC DERIVATIVE OF PYRAZOL[3,4-D]PYRIMIDIN-3-ONE, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai de Novo Pharmatech Co., Ltd. (CN) 2020-02-05 EP disclosed
CN-110734405-A Synthesis method of N- (6-aminohexyl) -N '-methyl-2, 2' -biimidazole 华东数字医学工程研究院 2020-01-31 CN disclosed
CN-106995397-B R-amisulpride medicinal salt, preparation method, crystal form and application thereof 河北医科大学 2020-01-14 CN disclosed
CN-110662541-A Polycyclic amines as opioid receptor modulators 王晓冬 2020-01-07 CN disclosed
CN-110403939-A For treating the tricyclic nitrogenous compound of N. gonorrhoeae infections GLAXOSMITHKLINE INTELECTUAL PROPERTY DEV LTD 2019-11-05 CN disclosed
CN-110317153-A A kind of N α-fluorenylmethyloxycarbonyl-N', N''- dioctyl phthalate acrylic-L-arginine preparation method 吉尔生化(上海)有限公司 2019-10-11 CN disclosed
CN-106659717-B Tricyclic nitrogen-containing compounds for the treatment of neisseria gonorrhoeae infections 葛兰素史密斯克莱知识产权发展有限公司 2019-09-06 CN disclosed
CN-110088100-A Pyrimidone derivatives as CDC7 inhibitor 癌症研究科技有限公司 2019-08-02 CN disclosed
CN-107250128-B Cyclic amine derivatives and its medical usage 东丽株式会社 2019-07-26 CN disclosed
CN-110041407-A A method of the Rayleigh synthesis acetic acid De She based on Fmoc dipeptides 南京肽业生物科技有限公司 2019-07-23 CN disclosed
CN-110028496-A A kind of synthetic method of teneligliptin related impurities 梯尔希(南京)药物研发有限公司 2019-07-19 CN disclosed
CN-110016055-A Organnic electroluminescent device and polycyclic compound for Organnic electroluminescent device 三星显示有限公司 2019-07-16 CN disclosed
US-20190214585-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2019-07-11 US disclosed
EP-3508490-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE Samsung Display Co., Ltd. (KR) 2019-07-10 EP disclosed
US-20190152941-A1 BENZAZEPINE DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai De Novo Pharmatech Co., Ltd. (CN) 2019-05-23 US disclosed
EP-3482775-A1 11C-LABELLED CATECHOL DERIVATIVE, POSITRON EMISSION TOMOGRAPHY (PET) PROBE FOR PHOSPHORYLATED TAU AGGREGATION INHIBITOR USING SAME, AND PRODUCTION METHODS THEREFOR National Center for Geriatrics and Gerontology (JP) 2019-05-15 EP disclosed
EP-3453707-A1 BENZAZEPINE DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai de Novo Pharmatech Co., Ltd. (CN) 2019-03-13 EP disclosed
CN-106279167-B Matrine compound derivative and preparation method and application thereof 中国医学科学院医药生物技术研究所 2018-11-13 CN disclosed
CN-108395437-A Deuterated compound and its medical usage 泰州华元医药科技有限公司 2018-08-14 CN disclosed
CN-108349879-A Synthesis of cyclohexanecarboxamide derivatives useful as sensates in consumer products 宝洁公司 2018-07-31 CN disclosed
CN-105189446-B Phloroglucin analog derivative and its purposes in treating neurodegenerative disease 中国医学科学院药物研究所 2018-07-20 CN disclosed
US-20180127358-A1 ANTI-INFLAMMATORY DRUG AND USES THEREOF KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2018-05-10 US disclosed
US-9905767-B2 High-molecular compound and light-emitting element using same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-02-27 US disclosed
CN-106957255-B Methylisoindoline of 5 bromines of one kind (R) N Boc 1 and its preparation method and application 上海馨远医药科技有限公司 2018-01-09 CN disclosed
CN-104663674-B Fungicide compound and mixture 杜邦公司 2017-11-03 CN disclosed
CN-107250129-A Cyclic amine derivatives and its medical usage 东丽株式会社 2017-10-13 CN disclosed
CN-107250128-A Cyclic amine derivatives and its medical usage 东丽株式会社 2017-10-13 CN disclosed
CN-107207462-A Cyclic amine derivatives and its medical usage 东丽株式会社 2017-09-26 CN disclosed
CN-107207489-A It is used as the acylamino- thiadiazoles derivative of nadph oxidase inhibitor 吉恩基奥泰克斯瑞士股份有限公司 2017-09-26 CN disclosed
EP-3214088-A1 METHOD FOR PRODUCING EUSHEARILIDES Tokyo University of Science Foundation (JP) 2017-09-06 EP disclosed
CN-107021962-A Fungicidal azocyclic amides 杜邦公司 2017-08-08 CN disclosed
CN-106986866-A Fungicidal azocyclic amides 杜邦公司 2017-07-28 CN disclosed
CN-106957255-A Methylisoindoline of 5 bromines of one kind (R) N Boc 1 and its preparation method and application 上海馨远医药科技有限公司 2017-07-18 CN disclosed
US-9688634-B2 Pest control agent ISHIHARA SANGYO KAISHA, LTD. (JP) 2017-06-27 US disclosed
CN-106659717-A Tricyclic nitrogen-containing compounds for the treatment of neisseria gonorrhoeae infections 葛兰素史密斯克莱知识产权发展有限公司 2017-05-10 CN disclosed
CN-104478805-B Fungicidal azacyclic amides 杜邦公司 2017-04-12 CN disclosed
US-9603833-B2 Benzene or thiophene derivative and use thereof as VAP-1 inhibitor R-TECH UENO, LTD. (JP) 2017-03-28 US disclosed
CN-104961646-B Mosapride active metabolites, preparation method and uses thereof 沈阳药科大学 2017-02-22 CN disclosed
CN-106414388-A Process for the manufacture of terphenyl compounds 索尔维特殊聚合物美国有限责任公司 2017-02-15 CN disclosed
CN-106279167-A Matrine compound derivative and preparation method and application thereof 中国医学科学院医药生物技术研究所 2017-01-04 CN disclosed
CN-104607250-B A kind of polyhedral oligomeric silsesquioxane dendritic macromole catalyst and application thereof 舒兰市金马化工有限公司 2016-11-30 CN disclosed
CN-104105697-B Bicyclic piperazines compound 霍夫曼-拉罗奇有限公司 2016-11-09 CN disclosed
CN-105998028-A Hydroxylamine compounds and methods of their use 科尔比制药公司 2016-10-12 CN disclosed
CN-105541649-A Preparation method of glutamic acid-5-benzyl ester-1-tert-butyl ester hydrochloride GL BIOCHEM (SHANGHAI) LTD 2016-05-04 CN disclosed
US-9249109-B2 Method for preparing dipeptidyl peptidase-IV inhibitor and intermediate DONG-A PHARMACEUTICAL CO., LTD. (KR) 2016-02-02 US disclosed
CN-105189446-A Phloroglucinol derivatives and application thereof in treatment of neurodegenerative disorder INST MATERIA MEDICA CAMS 2015-12-23 CN disclosed
US-20150336894-A1 PEST CONTROL AGENT ISHIHARA SANGYO KAISHA, LTD. (JP) 2015-11-26 US disclosed
EP-2934137-A1 PEST CONTROL AGENT Ishihara Sangyo Kaisha, Ltd. (JP) 2015-10-28 EP disclosed
US-20150207077-A1 HIGH-MOLECULAR COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-07-23 US disclosed
EP-2886534-A1 Benzene or thiophene derivative and use thereof as VAP-1 inhibitor R-Tech Ueno, Ltd. (JP) 2015-06-24 EP disclosed
US-20150166525-A1 BENZENE OR THIOPHENE DERIVATIVE AND USE THEREOF AS VAP-1 INHIBITOR R TECH UENO LTD (JP) 2015-06-18 US disclosed
CN-104607250-A Polyhedral oligomeric silsesquioxane dendritic macromolecule catalyst and application thereof SHULAN JINMA CHEMICAL CO LTD 2015-05-13 CN disclosed
CN-101888843-B Fungicidal azacyclic amides DU PONT 2015-04-15 CN disclosed
CN-103517909-B Novel anti-platelet compound addition salt GUANGZHOU HEERSHI PHARMA DEV CO LTD 2015-04-08 CN disclosed
US-8999989-B2 Benzene or thiophene derivative and use thereof as VAP-1 inhibitor R-TECH UENO, LTD. (JP) 2015-04-07 US disclosed
US-20150025241-A1 METHOD FOR PREPARING DIPEPTIDYL PEPTIDASE-IV INHIBITOR AND INTERMEDIATE DONG-A PHARMACEUTICAL. CO., LTD (KR) 2015-01-22 US disclosed
US-20140296183-A1 AMINE COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES MITSUBISHI TANABE PHARMA CORP (JP) 2014-10-02 US disclosed
US-8816084-B1 Crystals of morphinan derivative, manufacturing method thereof, and pharmaceutical composition using the same EVERLIGHT CHEMICAL INDUSTRIAL CORPORATION (TW) 2014-08-26 US disclosed
US-8809304-B2 Amine compound and use thereof for medical purposes MITSUBISHI TANABE PHARMA CORPORATION (JP) 2014-08-19 US disclosed
US-8785477-B2 Hexahydropyrrolo[3,4-b]pyrrole derivatives, preparation methods and pharmaceutical uses thereof SHANGHAI SUN-SAIL PHARMACEUTICAL SCIENCE & TECHNOLOGY CO., LTD. (CN) 2014-07-22 US disclosed
EP-2578586-B1 HEXAHYDROPYRROLO[3,4-b]PYRROLE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL USES THEREOF SHANGHAI SUN SAIL PHARMACEUTICAL SCIENCE & TECHNOLOGY CO LTD (CN) 2014-07-09 EP disclosed
WO-2014098259-A1 PEST CONTROL AGENT ISHIHARA SANGYO KAISHA, LTD. (JP) 2014-06-26 WO disclosed
CN-102596867-B Method for purification of fluorine-containing compound SHOWA DENKO KK 2014-06-11 CN disclosed
CN-103517909-A Novel anti-platelet compound addition salt GUANGZHOU HEERSHI PHARMA DEV CO LTD 2014-01-15 CN disclosed
CN-103497148-A Hydroxylamine compounds and methods of their use OTHERA HOLDING INC 2014-01-08 CN disclosed
EP-2669265-A2 Improved method for preparing dipeptidyl peptidase-IV inhibitor and intermediate Dong-A Pharmaceutical Co., Ltd. (KR) 2013-12-04 EP disclosed
CN-103420924-A Preparation method of Erlotinib Hydrochloride crystal form A ZHEJIANG JIUZHOU PHARM CO LTD 2013-12-04 CN disclosed
US-20130178500-A1 HEXAHYDROPYRROLO[3,4-b]PYRROLE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL USES THEREOF JIANGSU JINGLIXIN PHARMACEUTICAL TECHNOLOGY CO.,LTD. (CN) 2013-07-11 US disclosed
CN-101687786-B Hydroxylamine compounds and methods of use thereof OTHERA HOLDING INC 2013-05-22 CN disclosed
CN-103044320-A Preparation method of 4-pyridylaldehyde QIHE CHENGHUI FINE CHEMICAL CO LTD 2013-04-17 CN disclosed
EP-2578586-A1 HEXAHYDROPYRROLO[3,4-b]PYRROLE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL USES THEREOF Shanghai Sun-Sail Pharmaceutical Science & Technology Co., Ltd (CN) 2013-04-10 EP disclosed
US-20120215040-A1 FLUORINE-CONTAINING COMPOUND PURIFICATION METHOD SHOWA DENKO K.K. (JP) 2012-08-23 US disclosed
CN-102596867-A Method for purification of fluorine-containing compound SHOWA DENKO KK 2012-07-18 CN disclosed
CN-101454289-B Substituted tetrahydroisoquinoline compounds, their preparation and use in medicine ESTEVE LABOR DR 2012-07-04 CN disclosed
EP-2415753-A2 IMPROVED METHOD FOR PREPARING DIPEPTIDYL PEPTIDASE-IV INHIBITOR AND INTERMEDIATE Dong-A Pharmaceutical Co., Ltd. (KR) 2012-02-08 EP disclosed
US-20120016125-A1 METHOD FOR PREPARING DIPEPTIDYL PEPTIDASE-IV INHIBITOR AND INTERMEDIATE DONG-A PHARMACEUTICAL. CO., LTD (KR) 2012-01-19 US disclosed
EP-1961734-B1 AMINE COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES MITSUBISHI TANABE PHARMA CORP (JP) 2011-09-14 EP disclosed
EP-1389616-B1 3,4-Dihalobenzylpiperidine derivatives and their medical use MITSUBISHI TANABE PHARMA CORP (JP) 2011-07-27 EP disclosed
CN-101602734-B Method for preparing Erlotinib hydrochloride crystal form A ZHEJIANG JIUZHOU PHARM CO LTD 2011-07-20 CN disclosed
WO-2011052559-A1 METHOD FOR PURIFICATION OF FLUORINE-CONTAINING COMPOUND 昭和電工株式会社 (JP) 2011-05-05 WO disclosed
EP-2300430-A1 BENZENE OR THIOPHENE DERIVATIVE AND USE THEREOF AS VAP-1 INHIBITOR R-Tech Ueno, Ltd. (JP) 2011-03-30 EP disclosed
CN-101990401-A Dual pharmacophores-PDE 4-muscarinic antagonists GLAXO GROUP LTD 2011-03-23 CN disclosed
US-20110059957-A1 BENZENE OR THIOPHENE DERIVATIVE AND USE THEREOF AS VAP-1 INHIBITOR R-TECH UENO, LTD. (JP) 2011-03-10 US disclosed
CN-101921279-A Spirocyclic heterocyclic derivatives and methods of their use ADOLOR CORP 2010-12-22 CN disclosed
CN-101888843-A Fungicidal azacyclic amides DU PONT 2010-11-17 CN disclosed
CN-1668303-B Selective estrogen receptor modulators containing phenylsulfonyl groups LILLY CO ELI 2010-10-27 CN disclosed
US-20100222345-A1 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION 2010-09-02 US disclosed
CN-101602734-A A kind of preparation method of Erlotinib hydrochloride crystal form A ZHEJIANG JIUZHOU PHARMACEUTICA (CN) 2009-12-16 CN disclosed
CN-101600720-A Phosphoinositide 3-kinase inhibitor compounds and using method HOFFMANN LA ROCHE (CH) 2009-12-09 CN disclosed
WO-2009145360-A1 BENZENE OR THIOPHENE DERIVATIVE AND USE THEREOF AS VAP-1 INHIBITOR R-TECH UENO, LTD. (JP) 2009-12-03 WO disclosed
CN-100549004-C Spirocyclic heterocyclic derivatives and methods of use thereof ADOLOR CORP (US) 2009-10-14 CN disclosed
CN-101454289-A Substituted tetrahydroisoquinoline compounds, their preparation and use in medicine ESTEVE LABOR DR (ES) 2009-06-10 CN disclosed
US-20090137530-A1 Amine Compound and Use Thereof for Medical Purposes MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-05-28 US disclosed
CN-101443320-A Benzothiazole derivatives as beta 2 adrenoreceptor agonists ASTRAZENECA AB (SE) 2009-05-27 CN disclosed
EP-2049481-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS SmithKline Beecham Corporation (US) 2009-04-22 EP disclosed
US-7432381-B2 3-Substituted with a trialkoxysilylalkyl- or trialkoxysilylalkoxyalkyl- group; intermediates for adhesion promoters with improved volume shrinkage characteristics, enhanced corrosion resistance and enhanced curing properties HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2008-10-07 US disclosed
EP-1961734-A1 AMINE COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES Mitsubishi Tanabe Pharma Corporation (JP) 2008-08-27 EP disclosed
CN-101219145-A Quinazoline derivatives as VEGF inhibitors ASTRAZENECA AB (SE) 2008-07-16 CN disclosed
WO-2008021851-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION (US) 2008-02-21 WO disclosed
EP-1019358-B2 3,3-DIARYLPROPYLAMINES , THEIR USE AND PREPARATION PFIZER HEALTH AB (SE) 2007-09-12 EP disclosed
CN-1922169-A Spirocyclic heterocyclic derivatives and methods of use thereof ADOLOR CORP (US) 2007-02-28 CN disclosed
EP-1533292-B1 DIBENZYLAMINE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC (JP) 2007-02-14 EP disclosed
CN-1894243-A 4- (pyrazol-3-ylamino) pyrimidine derivatives for the treatment of cancer ASTRAZENECA AB (SE) 2007-01-10 CN disclosed
US-20060293280-A1 1,3-Oxathiolane-2-thione compounds HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 2006-12-28 US disclosed
CN-1871222-A CCR3 receptor antagonists HOFFMANN LA ROCHE (CH) 2006-11-29 CN disclosed
US-7115635-B2 Benzylpiperidine compound MITSUBISHI PHARMA CORPORATION (JP) 2006-10-03 US disclosed
US-20060154917-A1 Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators NEUROGEN CORPORATION (US) 2006-07-13 US disclosed
EP-1654300-A2 SILOXANE DERIVATIVES OF 1,3-OXATHIOLANE-2-THIONES, THEIR PREPARATION AND USE THEREOF Henkel Kommanditgesellschaft auf Aktien (DE) 2006-05-10 EP disclosed
CN-1250519-C Amine derivative with K channel regulation function and its preparing process and application INST OF TOXIC MEDICAL MATERIAL (CN) 2006-04-12 CN disclosed
CN-1250518-C Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application INST OF TOXIC MEDICAL MATERIAL (CN) 2006-04-12 CN disclosed
US-7022716-B2 Cyclic amine phenyl beta-3 adrenergic receptor agonists WYETH (US) 2006-04-04 US disclosed
EP-1321508-B1 Fragrance composition containing 3-(3-Hexenyl)-2-cyclopentenone TAKASAGO PERFUMERY CO LTD (JP) 2006-03-08 EP disclosed
CN-1229349-C Pyridine-3-carboxylic acid derivative PFIZER (US) 2005-11-30 CN disclosed
CN-1668303-A Selective estrogen receptor modulators containing phenylsulfonyl groups LILLY CO ELI (US) 2005-09-14 CN disclosed
CN-1205175-C Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science INST OF TOXICANT AND MEDICAMEN (CN) 2005-06-08 CN disclosed
US-6903067-B2 Fragrance composition containing 3-(3-hexenyl)-2-cyclopentenone TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-06-07 US disclosed
WO-2005016995-A1 SILOXANE DERIVATIVES OF 1,3-OXATHIOLANE-2-THIONES, THEIR PREPARATION AND USE THEREOF HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2005-02-24 WO disclosed
WO-2005016939-A2 SILOXANE DERIVATIVES OF 1,3-OXATHIOLANE-2-THIONES, THEIR PREPATATION AND USE THEREOF HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2005-02-24 WO disclosed
EP-1506976-A1 Siloxane derivatives of 1,3-oxathiolane-2-thiones, their preparation and use thereof Henkel Kommanditgesellschaft auf Aktien (DE) 2005-02-16 EP disclosed
WO-2005009384-A2 EGFR TYROSINE KINASE INHIBITORS IMCLONE SYSTEMS INCORPORATED (US) 2005-02-03 WO disclosed
WO-2005007087-A2 SUBSTITUTED (HETEROCYCLOALKYL)METHYL AZOLE DERIVATIVES AS C5A RECEPTOR MODULATORS NEUROGEN CORPORATION (US) 2005-01-27 WO disclosed
CN-1181822-C Use of 2-amino-3,4-dihydro-quinazolines for producing medicament for treating or preventing diseases caused by ischaemic conditions ���ĵ�˹ҩ��¹����޹�˾ 2004-12-29 CN disclosed
CN-1168714-C Arylpiperazine derivatives useful as uroselective alpha-adrenoceptor blockers ʵ 2004-09-29 CN disclosed
US-20040158071-A1 Chemokine inhibitors and stability in blood MITSUBISHI PHARMA CORPORATION (JP) 2004-08-12 US disclosed
CN-1495169-A Pyridine-3-carboxylic acid derivative 2004-05-12 CN disclosed
EP-1389616-A1 NOVEL BENZYLPIPERIDINE COMPOUND Mitsubishi Pharma Corporation (JP) 2004-02-18 EP disclosed
CN-1134442-C Pyrazolopyrimidinone cGMP PDE5 inhibitor, preparation method and application thereof and intermediate �������۸��¼��������������ι�˾ 2004-01-14 CN disclosed
EP-1043308-B1 PHENYLAMINOALKYLCARBOXYLIC ACID DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME KISSEI PHARMACEUTICAL (JP) 2003-09-24 EP disclosed
US-20030158080-A1 Fragrance composition containing 3-(3-hexenyl)-2-cyclopentenone TAKASAGO INTERNATIONAL CORPORATION (JP) 2003-08-21 US disclosed
US-20030144326-A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists WYETH 2003-07-31 US disclosed
EP-1321508-A2 Fragrance composition containing 3-(3-Hexenyl)-2-cyclopentenone Takasago International Corporation (JP) 2003-06-25 EP disclosed
US-6579871-B2 Phenyl oxazoles or thiazoles ELI LILLY AND COMPANY 2003-06-17 US disclosed
EP-0971709-B1 NOVEL COMPOUNDS USEFUL AS NEURO-PROTECTIVE AGENTS LILLY CO ELI (US) 2003-05-21 EP disclosed
EP-1019358-B1 3,3-DIARYLPROPYLAMINES , THEIR USE AND PREPARATION PHARMACIA AB (SE) 2003-05-07 EP disclosed
CN-1415596-A Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science INST OF TOXICANT AND MEDICAMEN (CN) 2003-05-07 CN disclosed
EP-1301482-A1 CYCLIC AMINE PHENYL BETA-3 ADRENERGIC RECEPTOR AGONISTS Wyeth (US) 2003-04-16 EP disclosed
US-20030050311-A1 Methods of using novel compounds as neuro-protective agents PANETTA JILL ANN (US) 2003-03-13 US disclosed
US-6525202-B2 E.g., substituted (4-amino-5-hydroxyphenyl)-oxy-)piperidinyl thiazolidin-2,4-dione; antidiabetic agents; atherosclerosis, gastrointestinal, metabolic disorders, glaucoma, neurogenetic inflammation, ocular hypertension and frequent urination WYETH 2003-02-25 US disclosed
CN-1384747-A Use of 2-amino-3, 4-dihydroquinolines for the production of a medicament for the treatment or prevention of diseases caused by ischemic conditions AVENTIS PHARMA GMBH (DE) 2002-12-11 CN disclosed
US-20020177595-A1 Novel compounds useful as neuro-protective agents PANETTA JILL ANN (US) 2002-11-28 US disclosed
EP-0826673-B1 ACETAMIDE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITION CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO (JP) 2002-11-20 EP disclosed
US-6472387-B1 Methods of using compounds as neuro-protective agents ELI LILLY AND COMPANY 2002-10-29 US disclosed
US-20020137736-A1 N-(4-methoxy-3-((methylamino)methyl)phenyl)-2 -thiophenecarboximidamide, for example; nitric oxide synthase inhibitors; treating hypoxia, ischemia, stroke, Parkinson's disease, anxiety, schizophrenia, migraine and pain ASTRAZENECA AB (SE) 2002-09-26 US disclosed
US-20020137750-A1 Amidine derivatives which are inhibitors of nitric oxide synthase ASTRAZENECA AB (SE) 2002-09-26 US disclosed
US-6448396-B2 2-((3,5-DIALKYL-4-HYDROXYPHENYL-4-(2-(AMINOALKYLPHENOXY)ETHYL) OXAZOLES; ANTIISCHEMIC AGENTS; REPERFUSION INJURY OF PERIPHERAL ORGANS; FREE RADICAL ANTAGONISTS; PARKINSON'S AND ALZHEIMER'S DISESES; DOWN'S SYNDROME; AMYOTROPHIC LATERAL S. ELI LILLY AND COMPANY 2002-09-10 US disclosed
CN-1365967-A Amine derivative with K channel regulation function and its preparing process and application INST OF TOXIC MEDICAL MATERIAL (CN) 2002-08-28 CN disclosed
CN-1365966-A Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application INST OF TOXIC MEDICAL MATERIAL (CN) 2002-08-28 CN disclosed
US-6436922-B1 TREATING IRRITABLE BOWEL SYNDROME AJINOMOTO CO., INC. (JP) 2002-08-20 US disclosed
US-6423709-B1 FOR THERAPY OF ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, AMYTROPHIC LATERAL SCLEROSIS OR CEREBRAL TRAUMA IN A MAMMAL ELI LILLY AND COMPANY 2002-07-23 US disclosed
US-6420377-B1 ENZYME INHIBITOR PROMOTING CELLULAR DIFFERENTIATION, AND FOR TREATING CANCER THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2002-07-16 US disclosed
US-20020065274-A1 METHODS OF USING NOVEL COMPOUNDS AS NEURO-PROTECTIVE AGENTS PANETTA JILL ANN (US) 2002-05-30 US disclosed
CN-1349417-A Contraceptive compositions containing 3,3-substituted indoline derivatives and use thereof AMERICAN HOME PROD (US) 2002-05-15 CN disclosed
US-6380213-B1 PHENYL OXAZOLES, THIAZOLES, OXAZOLINES, OXADIAZOLES AND BENZOXAZOLES ELI LILLY AND COMPANY 2002-04-30 US disclosed
US-20020028835-A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists WYETH 2002-03-07 US disclosed
US-6353025-B1 COMPOUNDS AS DRUGS KISSEI PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
EP-1180513-A1 CYCLIC AMIDE COMPOUNDS, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-02-20 EP disclosed
WO-2002006232-A1 CYCLIC AMINE PHENYL BETA-3 ADRENERGIC RECEPTOR AGONISTS WYETH (US) 2002-01-24 WO disclosed
EP-0735031-B1 N-acetylpiperazine derivative, antibacterial drug, and anti-ulcer drug SHISEIDO CO LTD (JP) 2002-01-23 EP disclosed
CN-1332740-A 5HT antagonists for antidepressant therapy PFIZER PROD INC (US) 2002-01-23 CN disclosed
CN-1329589-A N-aralkylamino 1,2,3, 4-tetrahydronaphthalenes as ligands of neuropeptide YY5 receptor ORTHO MCNEIL PHARM INC (US) 2002-01-02 CN disclosed
US-6313132-B1 FOR THERAPY OF URINARY INCONTINENCE, ACETYLCHOLINE-MEDIATED DISORDER PHARMACIA AB (SE) 2001-11-06 US disclosed
CN-1318052-A Arylpiperazine derivatives useful as uroselective alpha-adrenoceptor blockers RANBAXY LAB LTD (IN) 2001-10-17 CN disclosed
US-20010027194-A1 NOVEL COMPOUNDS USEFUL AS NEURO-PROTECTIVE AGENTS ELI LILLY AND COMPANY 2001-10-04 US disclosed
EP-0889043-B1 5,11-DIHYDRODIBENZ b,e] 1,4]OXAZEPINE DERIVATIVES AND DRUG COMPOSITIONS CONTAING THE DERIVATIVES AJINOMOTO KK (JP) 2001-08-29 EP disclosed
CN-1305478-A Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction PFIZER (US) 2001-07-25 CN disclosed
CN-1302297-A Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in control of helicobacter bacteria BYK GULDEN LOMBERG CHEM FAB (DE) 2001-07-04 CN disclosed
WO-2001046170-A1 AMIDINE DERIVATIVES WHICH ARE INHIBITORS OF NITRIC OXIDE SYNTHASE ASTRAZENECA AB (SE) 2001-06-28 WO disclosed
WO-2001046171-A1 AMIDINE DERIVATIVES WHICH ARE INHIBITORS OF NITRIC OXIDE SYNTHASE ASTRAZENECA AB (SE) 2001-06-28 WO disclosed
EP-0971709-A4 NOVEL COMPOUNDS USEFUL AS NEURO-PROTECTIVE AGENTS LILLY CO ELI (US) 2001-04-11 EP disclosed
US-6207673-B1 FOR CANCER THERAPY THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2001-03-27 US disclosed
CN-1284057-A Adamantane derivatives ASTRA ZENECA BRITISH LTD (GB) 2001-02-14 CN disclosed
US-6166216-A Compounds useful as neuro-protective agents ELI LILLY AND COMPANY (US) 2000-12-26 US disclosed
US-6156748-A Compounds useful as neuro-protective agents ELI LILLY AND COMPANY (US) 2000-12-05 US disclosed
EP-1043308-A1 PHENYLAMINOALKYLCARBOXYLIC ACID DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME Kissei Pharmaceutical Co., Ltd. (JP) 2000-10-11 EP disclosed
US-6127361-A FOR TREATMENT OR PREVENTION OF GASTROINTESTINAL MOVING FUNCTION DISORDERS, IRRITABLE BOWEL SYNDROME AJINOMO CO., INC. (JP) 2000-10-03 US disclosed
EP-1019358-A1 NOVEL COMPOUNDS, THEIR USE AND PREPARATION Pharmacia &amp; Upjohn AB (SE) 2000-07-19 EP disclosed
CN-1052723-C Bicyclic aromatic compounds as therapeutic agents KNOLL AG (DE) 2000-05-24 CN disclosed
EP-0988058-A2 COVALENT CONJUGATES OF TOPOISOMERASE I AND TOPOISOMERASE II INHIBITORS Yale University (US) 2000-03-29 EP disclosed
EP-0971709-A1 NOVEL COMPOUNDS USEFUL AS NEURO-PROTECTIVE AGENTS ELI LILLY AND COMPANY (US) 2000-01-19 EP disclosed
CN-1239889-A Novel compounds useful as neuroprotective agents LILLY CO ELI (US) 1999-12-29 CN disclosed
CN-1237963-A Quinoline derivatives inhibiting the action of growth factors such as VEGF ZENECA LTD (GB) 1999-12-08 CN disclosed
US-5972946-A NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1999-10-26 US disclosed
US-5952360-A Method for treating neuropathic pain ELI LILLY AND COMPANY (US) 1999-09-14 US disclosed
US-5942530-A Method for treating pain ELI LILLY AND COMPANY (US) 1999-08-24 US disclosed
WO-1999018091-A1 NOVEL COMPOUNDS USEFUL AS NEURO-PROTECTIVE AGENTS ELI LILLY AND COMPANY (US) 1999-04-15 WO disclosed
EP-0908186-A2 Method for treating pain ELI LILLY AND COMPANY (US) 1999-04-14 EP disclosed
EP-0908454-A2 Oxazoles, thiazoles, oxazolines, oxadiazoles and benzoxazoles useful as neuro-protective agents ELI LILLY AND COMPANY (US) 1999-04-14 EP disclosed
EP-0908180-A2 Use of phenyl oxazole or phenyl thiazole derivatives for treating pain ELI LILLY AND COMPANY (US) 1999-04-14 EP disclosed
EP-0906755-A2 Use of phenyl oxazole or phenyl thiazole derivatives for treating neuropathic pain ELI LILLY AND COMPANY (US) 1999-04-07 EP disclosed
WO-1999009979-A1 METHOD FOR TREATING NEUROPATHIC PAIN ELI LILLY AND COMPANY (US) 1999-03-04 WO disclosed
WO-1999009829-A1 METHOD FOR TREATING PAIN ELI LILLY AND COMPANY (US) 1999-03-04 WO disclosed
WO-1999009980-A1 METHOD FOR TREATING PAIN ELI LILLY AND COMPANY (US) 1999-03-04 WO disclosed
EP-0889043-A1 5,11-DIHYDRODIBENZ b,e] 1,4]OXAZEPINE DERIVATIVES AND DRUG COMPOSITIONS CONTAING THE DERIVATIVES Ajinomoto Co., Inc. (JP) 1999-01-07 EP disclosed
WO-1998043942-A1 NOVEL COMPOUNDS, THEIR USE AND PREPARATION PHARMACIA & UPJOHN AB (SE) 1998-10-08 WO disclosed
WO-1998040104-A2 COVALENT CONJUGATES OF TOPOISOMERASE I AND TOPOISOMERASE II INHIBITORS YALE UNIVERSITY (US) 1998-09-17 WO disclosed
US-5756505-A N-acylpiperazine derivative, antibacterial drug and anti-ulcer drug SHISEIDO CO., LTD. (JP) 1998-05-26 US disclosed
WO-1998015274-A1 NOVEL COMPOUNDS USEFUL AS NEURO-PROTECTIVE AGENTS ELI LILLY AND COMPANY (US) 1998-04-16 WO disclosed
EP-0826673-A1 ACETAMIDE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITION CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1998-03-04 EP disclosed
CN-1142817-A 1N-alkyl-N-arylpyrimidinamines and derivatives thereof DU PONT MERCK PHARMA (US) 1997-02-12 CN disclosed
CN-1133043-A Bicyclic aromatic compounds as therapeutic agents BOOTS CO PLC (DE) 1996-10-09 CN disclosed
EP-0735031-A1 N-acetylpiperazine derivative, antibacterial drug, and anti-ulcer drug SHISEIDO COMPANY LIMITED (JP) 1996-10-02 EP disclosed
EP-0495982-B1 BICYCLIC PYRIMIDINE DERIVATIVE, METHOD OF PRODUCING THE SAME, AND PHARMACEUTICAL PREPARATION CONTAINING THE SAME AS ACTIVE INGREDIENT TEIJIN LTD (JP) 1996-06-12 EP disclosed
US-5378700-A Against hypoxemia of respiratory diseases TEIJIN LIMITED (JP) 1995-01-03 US disclosed
CN-1025031-C 2-oxo-3,8-diaza-spiro [4,5] decane derivatives, pharmaceutical compositions containing such derivatives and process for preparing them RICHTER GEDEON VEGYESZET (HU) 1994-06-15 CN disclosed
CN-1024667-C process for preparing substituted aminomethyl tetralins and substituted aminomethyl hydrogenated benzopyrans and their salts BAYER AG (DE) 1994-05-25 CN disclosed
EP-0547705-A1 Pharmacologically active tricyclic benzotriazepine derivatives CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) 1993-06-23 EP disclosed
EP-0495982-A1 BICYCLIC PYRIMIDINE DERIVATIVE, METHOD OF PRODUCING THE SAME, AND PHARMACEUTICAL PREPARATION CONTAINING THE SAME AS ACTIVE INGREDIENT TEIJIN LIMITED (JP) 1992-07-29 EP disclosed
US-5068238-A Anticonvulsants, schizophrenia, sleep disorders, antiischemia agents and cognition activators RHONE-POULENC SANTE (FR) 1991-11-26 US disclosed
EP-0114273-B1 NEW PHARMACOLOGICALLY ACTIVE PYRAZOLOPYRIDINES GRUPPO LEPETIT S.p.A. (IT) 1991-11-06 EP disclosed
US-5047432-A Antidepressants THE BOOTS COMPANY PLC (GB) 1991-09-10 US disclosed
CN-1049349-A New 2-oxo-3,8-diaza spiro [4,5] decane derivative contains formula of medicine of these derivatives and preparation method thereof RICHTER GEDEON VEGYESZET (HU) 1991-02-20 CN disclosed
EP-0391414-A2 Benzazepine and benzothiazepine derivatives E.R. SQUIBB &amp; SONS, INC. (US) 1990-10-10 EP disclosed
US-4954508-A HYPOTENSIVE GRUPPO LEPETIT S.P.A. (IT) 1990-09-04 US disclosed
US-4946840-A Benzazepine and benzothiazepine derivatives E. R. SQUIBB & SONS, INC. (US) 1990-08-07 US disclosed
EP-0127167-B1 3-(4-PIPERIDINYL)-1,2-BENZISOTHIAZOLES AND DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1990-04-04 EP disclosed
CN-1039809-A The aminomethyl tetraline that replaces and the preparation of heterocycle homologue thereof BAYER AG (DE) 1990-02-21 CN disclosed
US-4902684-A Benzazepine and benzothiazepine derivatives E. R. SQUIBB & SONS, INC. (US) 1990-02-20 US disclosed
WO-1989012633-A1 BENZAZEPINE AND BENZOTHIAZEPINE DERIVATIVES E.R. SQUIBB & SONS, INC. (US) 1989-12-28 WO disclosed
US-4723008-A VIRICIDES NISSHIN FLOUR MILLING CO., LTD. (JP) 1988-02-02 US disclosed
EP-0097202-B1 HYDRAZINOPYRIDAZINE COMPOUND, PROCESS FOR PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENT TEIKOKU HORMONE MFG. CO., LTD. (JP) 1987-11-19 EP disclosed
US-4700002-A VIRICIDES; INTERFERON INDUCERS NISSHIN FLOUR MILLING CO., LTD. (JP) 1987-10-13 US disclosed
EP-0067105-B1 ALLYL AMINE MAO INHIBITORS MERRELL DOW FRANCE ET CIE (FR) 1987-09-23 EP disclosed
US-4658063-A Isoprenylamine derivatives NISSHIN FLOUR MILLING CO., LTD. (JP) 1987-04-14 US disclosed
US-4645862-A VIRICIDES; INTERFERON-INDUCING ABILITY NISSHIN FLOUR MILLING CO., LTD. (JP) 1987-02-24 US disclosed
EP-0205334-A2 Benzazepine derivatives E.R. Squibb &amp; Sons, Inc. (US) 1986-12-17 EP disclosed
CN-86100131-A The preparation and the application thereof of octahydro indolizine compound 1986-10-15 CN disclosed
US-4599333-A HYPOTENSIVE AGENTS TEIKOKU HORMONE MFG. CO., LTD. (JP) 1986-07-08 US disclosed
US-4558056-A PSYCHOLOGICAL DISORDERS HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1985-12-10 US disclosed
US-4524074-A TREATMENT OF PSYCHOSES HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1985-06-18 US disclosed
US-4495101-A Antiinflammatory 5H-tetrazolo (5,1-c)(1,4)benzodiazepine derivatives AMERICAN HOME PRODUCTS CORPORATION (US) 1985-01-22 US disclosed
EP-0127167-A2 3-(4-Piperidinyl)-1,2-benzisothiazoles and derivatives, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1984-12-05 EP disclosed
EP-0114273-A1 New pharmacologically active pyrazolopyridines GRUPPO LEPETIT S.p.A. (IT) 1984-08-01 EP disclosed
US-4458076-A ANALGESICS, ANTIPSYCHOTICS HOECHST-ROUSSEL PHARMACEUTICALS (US) 1984-07-03 US disclosed
US-4454158-A Allyl amine MAO inhibitors MERRELL TORAUDE ET COMPAGNIE (FR) 1984-06-12 US disclosed
EP-0097202-A1 Hydrazinopyridazine compound, process for production thereof, and use thereof as medicament TEIKOKU HORMONE MFG. CO., LTD. (JP) 1984-01-04 EP disclosed
US-4386084-A BACTERICIDES; SULFONAMIDE POTENTIATION BASF AKTIENGESELLSCHAFT (DE) 1983-05-31 US disclosed
EP-0009655-B1 6-AMINO SUBSTITUTED N-PYRROLYL-3-PYRIDAZINE AMINES, THEIR PREPARATION, AND PHARMACEUTICALLY ANTIHYPERTENSIVE COMPOSITIONS CONTAINING THEM GRUPPO LEPETIT S.P.A. (IT) 1983-05-11 EP disclosed
EP-0023385-B1 ETHANAMINE DERIVATIVES, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS BEECHAM GROUP PLC (GB) 1982-12-15 EP disclosed
EP-0067105-A2 Allyl amine MAO inhibitors MERRELL DOW FRANCE ET CIE (FR) 1982-12-15 EP disclosed
US-4338333-A ANTIOBESITY, HYPOGLYCEMIC BEECHAM GROUP LIMITED (GB) 1982-07-06 US disclosed
US-4318925-A 4-Homoisotwistane derivatives SUMITOMO CHEMICAL CO., LTD. (JP) 1982-03-09 US disclosed
EP-0023385-A1 Ethanamine derivatives, their preparation and use in pharmaceutical compositions BEECHAM GROUP PLC (GB) 1981-02-04 EP disclosed
US-4247551-A N-Pyrrolyl-pyridazineamines and their use as antihypertensive agents GRUPPO LEPETIT S.P.A. (IT) 1981-01-27 US disclosed
EP-0009655-A1 6-Amino substituted N-pyrrolyl-3-pyridazine amines, their preparation, and pharmaceutically antihypertensive compositions containing them GRUPPO LEPETIT S.P.A. (IT) 1980-04-16 EP disclosed
US-4166062-A HYPOTENSIVE AGENTS, CNS, ANTIDEPRESSANTS THE UPJOHN COMPANY (US) 1979-08-28 US disclosed
US-4018922-A NEUROLEPTICS, ANALGESICS, SPASMOLYTICS, AND ANTIHISTAMINES ROUSSEL-UCLAF (FR) 1977-04-19 US disclosed
US-4018922-A NEUROLEPTICS, ANALGESICS, SPASMOLYTICS, AND ANTIHISTAMINES ROUSSEL-UCLAF (FR) 1977-04-19 US disclosed